CLOs on the Move

OncoGenex

www.OncoGenex.com

 
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in ...
  • Number of Employees: 25-100
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

CanReg

CanReg, Inc. is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Patient Focus Systems

Patient Focus Systems is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

National Dental Association

National Dental Association is a Washington, DC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

BDF

BDF is a Morristown, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CHC Wellbeing

Wellness programs are out. Wellbeing strategies are in. To thrive today, organizations must be trustworthy while nurturing a culture where people do their best work. There’s no shortcut to true potential, but CHC has a proven roadmap to reduce benchmar...